Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats

Atherosclerosis

Volumn 215, Issue 1, 2011, Pages 43-51

  Kanai, Saeko ^a   Uto, Kenta ^a   Honda, Kazuho ^a   Hagiwara, Nobuhisa ^a   Oda, Hideaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial medial calcification; Eicosapentaenoic acid; Macrophage; MCP 1; MMP 9

Indexed keywords

ALKALINE PHOSPHATASE; GELATINASE A; GELATINASE B; ICOSAPENTAENOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PHYTOMENADIONE; TRANSCRIPTION FACTOR RUNX2; WARFARIN;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CALCIFICATION; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AORTA; CALCINOSIS; CHEMOKINE CCL2; EICOSAPENTAENOIC ACID; ILIAC ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN K 1; WARFARIN;

EID: 79952103048     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.001     Document Type: Article

References (32)

1. Everhart J.E., Pettitt D.J., Knowler W.C., Rose F.A., Bennett P.H. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 1988, 31:16-23.
2. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
3. Hruska K.A., Mathew S., Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005, 97:105-114.
4. Demer L.L., Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117:2938-2948.
5. Aikawa E., Nahrendorf M., Figueiredo J.L., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007, 116:2841-2850.
6. Clarke M.C., Littlewood T.D., Figg N., et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008, 102:1529-1538.
7. Mizobuchi M., Towler D., Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009, 20:1453-1464.
8. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
9. von Schacky C. n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 2007, 66:166-170.
10. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
11. Price P., Faus S., Williamson M. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998, 18:1400-1407.
12. Price P.A., Kaneda Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb Res 1987, 46:121-131.
13. Giachelli Molecular and cellular biology of osteopontin:: Potential role in cardiovascular disease. Trends Cardiovasc Med 1995, 5:88.
14. Aubin J.E., Liu F., Malaval L., Gupta A.K. Osteoblast and chondroblast differentiation. Bone 1995, 17:77S-83S.
15. Qin X., Corriere M.A., Matrisian L.M., Guzman R.J. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006, 26:1510-1516.
16. Vyavahare N., Jones P.L., Tallapragada S., Levy R.J. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol 2000, 157:885-893.
17. Aikawa E., Aikawa M., Libby P., et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009, 119:1785-1794.
18. Tintut Y., Patel J., Territo M., Saini T., Parhami F., Demer L.L. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 2002, 105:650-655.
19. Luo G., Ducy P., McKee M.D., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
20. Towler D.A., Bidder M., Latifi T., Coleman T., Semenkovich C.F. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 1998, 273:30427-30434.
21. Price P.A., Faus S.A., Williamson M.K. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001, 21:817-824.
22. Essalihi R., Zandvliet M.L., Moreau S., et al. Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension. J Hypertens 2007, 25:1879-1886.
23. Daviglus M.L., Stamler J., Orencia A.J., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336:1046-1053.
24. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
25. London B., Albert C., Anderson M.E., et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007, 116:e320-e335.
26. Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
27. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
28. Salari P., Rezaie A., Larijani B., Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008, 14:RA37-RA44.
29. Abedin M., Lim J., Tang T., Park D., Demer L., Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res 2006, 98:727-729.
30. Schlemmer C.K., Coetzer H., Claassen N., et al. Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1998, 59:221-227.
31. Simionescu A., Philips K., Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 2005, 334:524-532.
32. Bouvet C., Moreau S., Blanchette J., de Blois D., Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 2008, 28:856-862.